SCNI fundamentals
An in-depth look to Scinai Immunotherapeutics Ltd. operating, investing, and financing activities
SCNI free cash flow for Q4 23 is -1.54 M USD. For 2023, SCNI free cash flow was -9.99 M USD and operating cash flow was -9.36 M USD.
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM